SciELO - Scientific Electronic Library Online

 
vol.142 issue5Longitudinal study of three families with familial Parkinson's diseasePhysiopathology of prion diseases author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Gaceta médica de México

On-line version ISSN 2696-1288Print version ISSN 0016-3813

Abstract

CABALLERO-CABALLERO, Rocío; HERNANDEZ-RIVERA, E.Gabriela  and  LOPEZ-KARPOVITCH, Joseph X.. Ten year experience with ocular lymphomas and ocular adnexae lymphomas. Gac. Méd. Méx [online]. 2006, vol.142, n.5, pp.393-397. ISSN 2696-1288.

Background. Ocular lymphomas and ocular adnexae lymphomas (OL and O AL) constitute 7-8% of all extranodal lymphomas. Objective. Describe the clinical, morphologic and immunophenotypic characteristics of OAL seen in our hospital. Material and methods. Retrospective analysis of patient records with OL and OAL between July 1994 and July 2005. The following data was analyzed: Clinical presentation, therapy, treatment response, overall survival and disease free survival. Results. Ten patientswith OL and OAL were identified. Of these, 8 were women and 2 men. Median age was 50. Eight of 10 patients achieved complete remission, 6 of the 6 presenting MALT Lymphoma. Two patients with stage IV had refractory disease. Conclusions. In our series 0.02% of lymphomas were OL and OAL of a total 498 LNH. MALT lymphomas appear at a more advanced age, sixty percent of the cases were MALT lymphomas and were diagnosed during their early stages. Patients were followed during 21 months, global survival was 100%, free illness survival had a mean of 868 days and a survival median of 442 days.

Keywords : Extranodal lymphoma; ocular lymphoma; adnexae; lymphoid tissue; conjuntival hyperemia.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License